Your browser doesn't support javascript.
loading
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature.
Giannone, G; Scotto, G; Katsaros, D; De Giorgi, U; Farolfi, A; Borella, F; Cosma, S; Ferrero, A; Mangiacotti, S; Villa, M; Tuninetti, V; Ghisoni, E; Turinetto, M; Mittica, G; Gemmiti, S; Zavallone, L; Aglietta, M; Pasini, B; Di Maio, M; Valabrega, G.
Affiliation
  • Giannone G; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy; Department of Oncology, University of Turin, Turin, Italy. Electronic address: gaia.giannone@ircc.it.
  • Scotto G; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy; Department of Oncology, University of Turin, Turin, Italy.
  • Katsaros D; Department of Surgical Science and Gynecology, Azienda Ospedaliero Universitaria, Città della Salute, presidio S. Anna, University of Turin, Turin, Italy.
  • De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Farolfi A; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Borella F; Department of Surgical Science and Gynecology, Azienda Ospedaliero Universitaria, Città della Salute, presidio S. Anna, University of Turin, Turin, Italy.
  • Cosma S; Department of Surgical Science and Gynecology, Azienda Ospedaliero Universitaria, Città della Salute, presidio S. Anna, University of Turin, Turin, Italy.
  • Ferrero A; Academic Department Gynaecology and Obstetrics, University of Turin, A.O. Ordine Mauriziano, Turin, Italy.
  • Mangiacotti S; University of Turin, Turin, Italy.
  • Villa M; Academic Department Gynaecology and Obstetrics, University of Turin, A.O. Ordine Mauriziano, Turin, Italy.
  • Tuninetti V; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy; Department of Oncology, University of Turin, Turin, Italy.
  • Ghisoni E; Department of Oncology, Lausanne University Hospital, Switzerland; Ludwig Institute for Cancer Research, Lausanne, Switzerland.
  • Turinetto M; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy; Department of Oncology, University of Turin, Turin, Italy.
  • Mittica G; Unit of Oncology, ASL Verbano Cusio Ossola (VCO), Omegna (VB), Italy.
  • Gemmiti S; Department of Surgical Science and Gynecology, Azienda Ospedaliero Universitaria, Città della Salute, presidio S. Anna, University of Turin, Turin, Italy.
  • Zavallone L; Department of Medical Oncology, Infermi Hospital, Biella, Italy.
  • Aglietta M; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy; Department of Oncology, University of Turin, Turin, Italy.
  • Pasini B; Department of Medical Sciences, University of Turin, Turin, Italy.
  • Di Maio M; Department of Oncology, A.O. Ordine Mauriziano Hospital, University of Turin, Turin, Italy.
  • Valabrega G; Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy; Department of Oncology, University of Turin, Turin, Italy.
Gynecol Oncol ; 162(1): 80-87, 2021 07.
Article in En | MEDLINE | ID: mdl-33896588

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / BRCA1 Protein / BRCA2 Protein / Drug Hypersensitivity Type of study: Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / BRCA1 Protein / BRCA2 Protein / Drug Hypersensitivity Type of study: Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2021 Document type: Article